Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to test the possibility that a combination of three drugs,
pomalidomide and everolimus with dexamethasone, may improve patient responses when compared
with use of either drug alone, with dexamethasone in refractory/relapsed multiple myeloma.